SAUHF (SAUHF) Stock Price & Analysis
SAUHF (SAUHF) fell 2.99% to USD 118.3 as of July 25, 2026 at 03:58 UTC, according to Nexqual real-time market data.
SAUHF last closed at USD 121.95; the session ranged USD 135–135 on volume of 1,000 shares. Market capitalization is $18.97B, with a 52-week range of USD 93.18–139.55 (PNK). Source: Nexqual, July 25, 2026 at 03:58 UTC.
Key Statistics (as of July 25, 2026 at 03:58 UTC)
| Price | USD 118.3 |
|---|---|
| Change | ▼ 2.99% (down) |
| Previous Close | USD 121.95 |
| Open | USD 135 |
| Day Range | USD 135 – 135 |
| 52-Week Range | USD 93.18 – 139.55 |
| Volume | 1,000 shares |
| Market Cap | $18.97B |
| Exchange | PNK |
Technical Analysis (SAUHF)
Nexqual's technical model rates SAUHF "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:58 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 34.78 (neutral) |
| vs SMA50 | Below (USD 122.56) |
| MACD | -0.83 (negative) |
Analyst Ratings (SAUHF)
Wall Street analysts rate SAUHF "None", per Nexqual as of July 25, 2026 at 03:58 UTC.
| Consensus Rating | None |
|---|
Earnings (SAUHF)
| Next Earnings Date | 2026-08-19 |
|---|---|
| Revenue Estimate | $674.63M |
Source: Nexqual, July 25, 2026 at 03:58 UTC.
Financials & Fundamentals (SAUHF)
| Total Revenue | $2.61B |
|---|---|
| Revenue Growth (YoY) | +2.20% |
| Gross Margin | +70.10% |
| Operating Margin | +23.76% |
| Profit Margin | +13.66% |
| ROE | +17.01% |
| Debt / Equity | 19.35 |
| Current Ratio | 2.21 |
| Total Cash | $489.57M |
| Total Debt | $418.93M |
| Free Cash Flow | $343.69M |
Source: Nexqual, July 25, 2026 at 03:58 UTC.
Financial Health Score (SAUHF)
Nexqual rates SAUHF's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 03:58 UTC.
| Growth | Mixed — Revenue +4.1% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 70%, operating 24% |
| Balance Sheet | Strong — $490M cash vs $419M debt, net cash position |
| Cash Flow | Solid — FCF $344M, 13% margin |
| Efficiency | Solid — ROE 17%, ROA 11.1% |
Ownership (SAUHF)
| Insider Ownership | +28.80% |
|---|---|
| Institutional Ownership | +41.27% |
| Shares Outstanding | 159.45M |
| Float | 107.92M |
Source: Nexqual, July 25, 2026 at 03:58 UTC.
Leadership (SAUHF)
SAUHF is led by Guillaume Daniellot (age 55), CEO, Interim Head of Dental Service Organizations & Member of Executive Management Board, per Nexqual as of July 25, 2026 at 03:58 UTC.
| CEO, Interim Head of Dental Service Organizations & Member of Executive Management Board | Guillaume Daniellot (age 55) |
|---|---|
| CFO & Member of Executive Management Board | Isabelle Wege (age 40) |
| Chief Technology & Information Officer and Member of Executive Management Board | Thomas Friese (age 50) |
| Executive VP of Latin America, President Neodent & Member of Executive Management Board | Alexei Costa (age 47) |
Major Backers & Investors (SAUHF)
Notable institutional backers of SAUHF include Morgan Stanley, Fidelity, AIM Intl Mutual Fd.s -Invesco Intl Growth Fd., according to Nexqual as of July 25, 2026 at 03:58 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Morgan Stanley | 0.31% |
| Fidelity | 0.26% |
| AIM Intl Mutual Fd.s -Invesco Intl Growth Fd. | 0.2% |
| Charles Schwab | 0.15% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.97% |
| BlackRock | 0.76% |
Source: Nexqual, July 25, 2026 at 03:58 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SAUHY | Straumann Holding AG | USD 11.64 | ▼ 1.61% |
| CLPBF | Coloplast AS | USD 64 | ▲ 0% |
| TRUMF | TERUMO CORP | USD 12.76 | ▼ 6.25% |
| SONVF | Sonova Holding AG | USD 261.44 | ▲ 0% |
| SDMHF | Sartorius Stedim Biotech | USD 193 | ▲ 0.78% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:58 UTC. This page is informational and not investment advice.